In a recent episode of Diabetes Dialogue: Technology, Therapeutics, and Real-World Perspectives, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, were joined by two experts, Allison Evert, MS, RD, CDCES, and Dr. Savitha Subramanian, MD, to discuss the evolving role of Registered Dietitian Nutritionists (RDNs) in managing obesity, particularly in patients undergoing incretin-based therapies. The discussion revolved around their joint publication, Incretin-Based Therapies and Lifestyle Interventions: The Evolving Role of Registered Dietitian Nutritionists in Obesity Care, which highlights the critical contributions of dietitians to improving patient outcomes in diabetes and obesity care.
The episode explored the synergistic effects of combining GLP-1 receptor agonists with lifestyle interventions, emphasizing how RDNs can enhance patient adherence to medication, manage side effects, and provide vital education. A central focus of the conversation was the role dietitians play in mitigating common side effects such as nausea, diarrhea, and constipation, which are known to lead to high medication discontinuation rates during the first year of treatment. Evert and Subramanian underscored the importance of addressing these side effects through appropriate dietary modifications, including guidance on preventing nutrient deficiencies and muscle loss, especially during periods of rapid weight loss.
Both experts stressed the need for RDNs to work alongside the broader care team to ensure patients are educated on the best dietary practices that support long-term success. They also discussed the practical challenges of integrating dietitians into multidisciplinary care teams, particularly in healthcare settings where resources may be limited. To bridge this gap, the paper offers valuable tools, such as detailed figures and guidelines, aimed at helping clinicians provide effective patient education and medication management.
In concluding, the conversation emphasized that a collaborative, team-based approach—incorporating dietitians, pharmacists, and advanced practice providers—is essential for optimizing patient outcomes. With the right support, patients can better manage their weight and diabetes, improving the overall efficacy of incretin therapies.
Sugar-Sweetened Beverages Contribute to Millions of Diabetes and Heart Disease Cases Worldwide
Sugary Drinks Fuel Global Diabetes and Cardiovascular Disease Epidemic
The Hidden Risk: Type 2 Diabetes and Increased Infection Vulnerability
